Geron (GERN) Other Accumulated Expenses (2011 - 2024)
Geron's (GERN) quarterly Other Accumulated Expenses came in at $2.1 million in Q4 2024, up 155.65% year-on-year from $814000.0 in Q1 2024, and down 34.29% quarter-over-quarter from $3.2 million in Q3 2024.
Geron (GERN) Other Accumulated Expenses (2011 - 2024) Analysis & Trends
Geron has disclosed Other Accumulated Expenses across 14 years of filings, most recently posting $2.1 million for Q4 2024.
- Other Accumulated Expenses for Q4 2024 came in at $2.1 million, up 155.65% year-over-year; the trailing twelve-month figure through Dec 2024 was $2.1 million (up 155.65% YoY), and the FY2024 annual result was $2.1 million, up 155.65% from the prior year.
- Other Accumulated Expenses came in at $2.1 million for Q4 2024 at Geron, down from $3.2 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $3.2 million in Q3 2024 to a low of $366000.0 in Q2 2022.
- The 5-year median for Other Accumulated Expenses is $1.2 million (2023), against an average of $1.3 million.
- Across the five-year window, Other Accumulated Expenses soared 452.19% in 2023 and decreased 16.72% in 2024, its largest moves.
- Geron's Other Accumulated Expenses stood at $388000.0 in 2020, then soared by 39.43% to $541000.0 in 2021, then slipped by 5.73% to $510000.0 in 2022, then jumped by 59.61% to $814000.0 in 2023, then surged by 155.65% to $2.1 million in 2024.
- The last three Other Accumulated Expenses figures came in at $2.1 million (Q4 2024), $3.2 million (Q3 2024), and $1.7 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Geron | 729,618.77 | 729,618.77 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 2.08 Mn |
| Sep 30, 2024 | 3.17 Mn |
| Jun 30, 2024 | 1.68 Mn |
| Mar 31, 2024 | 1.65 Mn |
| Dec 31, 2023 | 814,000.00 |
| Sep 30, 2023 | 2.21 Mn |
| Jun 30, 2023 | 2.02 Mn |
| Mar 31, 2023 | 1.66 Mn |
| Dec 31, 2022 | 510,000.00 |
| Sep 30, 2022 | 664,000.00 |
| Jun 30, 2022 | 366,000.00 |
| Mar 31, 2022 | 555,000.00 |
| Dec 31, 2021 | 541,000.00 |
| Dec 31, 2020 | 388,000.00 |
| Dec 31, 2019 | 207,000.00 |
| Dec 31, 2018 | 461,000.00 |
| Sep 30, 2018 | 884,000.00 |
| Jun 30, 2018 | 724,000.00 |
| Mar 31, 2018 | 942,000.00 |
| Dec 31, 2017 | 138,000.00 |